Outcome Measures of New Technologies in Uveal Melanoma: Review from the European Vision Institute Special Interest Focus Group Meeting



Beenakker, Jan-Willem M, Brouwer, Niels J, Chau, Cindy, Coupland, Sarah E ORCID: 0000-0002-1464-2069, Fiorentzis, Miltiadis, Heimann, Heinrich, Heufelder, Jens, Joussen, Antonia M, Kiilgaard, Jens F, Kivelä, Tero T
et al (show 9 more authors) (2023) Outcome Measures of New Technologies in Uveal Melanoma: Review from the European Vision Institute Special Interest Focus Group Meeting. Ophthalmic Research, 66 (1). pp. 14-26.

Access the full-text of this item by clicking on the Open Access link.

Abstract

<jats:p>Uveal Melanoma (UM) is the most common primary intra-ocular tumor in adults. New diagnostic procedures and basic science discoveries continue to change our patient management paradigms. A recent meeting of the European Vision Institute (EVI) special interest focus group was held on “Outcome Measures of New Technologies in Uveal Melanoma”, addressing the latest advances in UM, starting with genetic developments, then moving on to imaging and treatment of the primary tumor, as well as to investigating the most recent developments in treating metastases, and eventually taking care of the patient’s wellbeing. This review highlights the meeting’s presentations in the context of the published literature.</jats:p>

Item Type: Article
Uncontrolled Keywords: European Ocular Oncology Group and the International Society of Ocular Oncology, Humans, Melanoma, Uveal Neoplasms, Group Processes, Adult, Outcome Assessment, Health Care
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Systems, Molecular and Integrative Biology
Depositing User: Symplectic Admin
Date Deposited: 24 May 2022 08:30
Last Modified: 04 Jan 2024 21:35
DOI: 10.1159/000524372
Open Access URL: https://doi.org/10.1159/000524372
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3155386